Marples B, Scott SD, Hendry JH, et al. Development of synthetic promoters for radiation-mediated gene therapy[J]. Gene Ther，2000, 7(6): 511-517.
[3]
Scott SD, Joiner MC, Marples B. Optimizing radiation-responsive gene promoters for radiogenetic cancer therapy[J]. Gene Ther, 2002, 9(20):1 396-1 402.
[4]
Huber BE, Austin EA, Richards CA, et al. Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: Significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase[J]. Proc Natl Acad Sci USA, 1994, 91(17): 8 302-8 306.
[5]
Dropuli B. Lentiviral vectors: Their molecular design, safety, and use in laboratory and preclinical research[J]. Hum Gene Ther, 2011, 22(6): 649-657.
[6]
Danielsen S, Kilstrup M, Barilla K, et al. Characterization of the Escherichia coli codBA operon encoding cytosine permease and cytosine deaminase[J]. Mol Microbiol, 1992, 6(10): 1 335-1 344.
